Announce Date | 05/06/2025 |
EPS Normalized Actual | $2.14 (Miss by $-0.04) |
EPS GAAP Actual | $2.14 (Miss by $-0.04) |
Revenue Actual | $6.788B |
Revenue Surprise | Beat by $6788M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 15.64333 | 19.6 | 6.83627 | 21.18899 | 1 |
Dec 2028 | 9.16 | 33.47 | 8.55673 | 9.76564 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.38 | 0.38 | 6.788B | 9.81% | 6788M |
FQ4 2024 (Dec 2024) | 2.71 | 2.71 | 5.382B | -7.69% | 5382M |
FQ3 2024 (Sep 2024) | 3.83 | 3.83 | 6.55B | 100% | 6550M |
FQ2 2024 (Jun 2024) | 2.58 | 2.58 | 5.273B | 100% | 5273M |
FQ1 2024 (Mar 2024) | 2.79 | 2.79 | 6.122B | 100% | 6122M |
FQ4 2023 (Dec 2023) | -0.11 | -0.11 | 5.796B | 100% | 5796M |
FQ3 2012 (Sep 2012) | 0 | 0 | 4.031B | 100% | 4031M |
FQ4 2012 (Dec 2012) | 0 | 0 | 3.898B | 100% | 3898M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Sep 2029) | 4.6965 | -- | 3.80367 | 5.85474 | 1 |
FQ2 2029 (Jun 2029) | 3.03 | -- | 2.45398 | 3.77725 | 1 |
FQ1 2029 (Mar 2029) | 3.333 | -- | 2.69938 | 4.15497 | 2 |
FQ4 2028 (Oct 2028) | 5.3433 | -- | 5.18105 | 5.54342 | 1 |
FQ3 2028 (Jul 2028) | 4.1141 | -- | 3.98918 | 4.26818 | 1 |
FQ2 2028 (Jun 2028) | 3.1546 | -- | 2.77679 | 3.40382 | 2 |
FQ1 2028 (Mar 2028) | 1.5004 | -- | 1.3207 | 1.61894 | 2 |
FQ4 2027 (Oct 2027) | 4.5289 | -- | 4.39138 | 4.69852 | 0 |
FQ3 2027 (Jul 2027) | 3.4871 | -- | 3.38121 | 3.6177 | 0 |
FQ2 2027 (Jun 2027) | 2.9156 | -- | 2.56641 | 3.14594 | 1 |
FQ1 2027 (Mar 2027) | 1.3867 | -- | 1.22062 | 1.49625 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2029 (Sep 2029) | 9.65B | -- | 8.24B | 11.48B | 2 |
FQ2 2029 (Jun 2029) | 9.46B | -- | 8.08B | 11.26B | 2 |
FQ1 2029 (Mar 2029) | 9.28B | -- | 7.92B | 11.04B | 3 |
FQ4 2028 (Oct 2028) | 7.27B | -- | 7.1B | 7.47B | 0 |
FQ3 2028 (Jul 2028) | 7.2B | -- | 7.03B | 7.4B | 0 |
FQ2 2028 (Jun 2028) | 5.77B | -- | 5.24B | 6.12B | 0 |
FQ1 2028 (Mar 2028) | 5.72B | -- | 5.19B | 6.07B | 0 |
FQ4 2027 (Oct 2027) | 6.99B | -- | 6.83B | 7.2B | 0 |
FQ3 2027 (Jul 2027) | 6.93B | -- | 6.77B | 7.13B | 0 |
FQ2 2027 (Jun 2027) | 5.56B | -- | 5.04B | 5.89B | 1 |
FQ1 2027 (Mar 2027) | 5.5B | -- | 5B | 5.84B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
1
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.38 | 0.38 | 100% | |
FQ4 2024 (Dec 2024) | 2.71 | 2.71 | 100% | |
FQ3 2024 (Sep 2024) | 3.83 | 3.83 | 100% | |
FQ2 2024 (Jun 2024) | 2.58 | 2.58 | 100% | |
FQ1 2024 (Mar 2024) | 2.79 | 2.79 | 100% | |
FQ4 2023 (Dec 2023) | -0.11 | -0.11 | 100% | |
FQ3 2012 (Sep 2012) | 0 | 0 | NAN% | |
FQ4 2012 (Dec 2012) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $6.79B | $6788M | 100% |
FQ4 2024 (Dec 2024) | $0B | $5.38B | $5382M | 100% |
FQ3 2024 (Sep 2024) | $0B | $6.55B | $6550M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.27B | $5273M | 100% |
FQ1 2024 (Mar 2024) | $0B | $6.12B | $6122M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.8B | $5796M | 100% |
FQ3 2012 (Sep 2012) | $0B | $4.03B | $4031M | 100% |
FQ4 2012 (Dec 2012) | $0B | $3.9B | $3898M | 100% |